Their target prediction and pathway analysis showed that miR-126 can regulate key molecules and critical pathways involved in ccRCC tumor development and progression, including the IGF1R, BCL2, HIF-1, VEGF, mTOR, and PI3K-Akt signaling pathways. This evidence concerns the gene MTOR and neoplasm.